OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
May 13, 2023
This new data indicates that the peanut patch was efficacious and safe in children with peanut allergies in this age bracket, expanding the body of research on desensitization for toddlers and young children.
There have been long stretches of time between the innovation of epinephrine delivery in the allergy space.
May 10, 2023
Bryn Pharma is planning to submit the New Drug Application for Utuly this year and expects to receive approval early next year.
May 05, 2023
Data presented at the American Society for Clinical Pharmacology and Therapeutics annual meeting show promise for Utuly, a novel intranasal epinephrine spray for treating anaphylaxis.
March 28, 2023
New data on peanut allergy and Pediatric Quality of Life Inventory scores sheds light on the burden of allergy on adolescents.
March 22, 2023
“These findings are exciting for us, and our overarching goal is to develop microbial biotherapeutics to treat food allergies," Mustafa Özçam says in an interview with HCPLive.
March 07, 2023
In a recent letter to the editor, a newly-developed tool to assess one’s satisfaction with life when dealing with food allergy was introduced.
A recent study reviewed several educational interventions designed to promote food allergy literacy and knowledge for both parents and children.
March 03, 2023
Data from AAAAI 2023 suggests that gut microbial composition, function, and metabolic activity are implicated in the efficacy of peanut oral immunotherapy in children with peanut allergy.
March 01, 2023
Recent data, presented at the AAAAI annual meeting, showed that oral sesame desensitization through crushed seeds and tahini was efficacious and safe for pediatric patients.